If you are having trouble viewing this e-mail click here
European Research Infrastructures
for Poverty Related Diseases
Newsletter January 2015

Deadline 27 February 2015

EURIPRED is a EC-funded (FP7) infrastructure project to facilitate and support translational research for poverty related diseases, such as HIV, TB, malaria and hepatitis. The services provided by EURIRPED can be accessed for FREE by European scientists.

The EURIPRED services are:
•    Access to biological materials and reference reagents/ standards – NIBSC - CFAR
•    Access to vaccine adjuvant & formulation studies – VFL - UNIL
•    Access to microarray facility for screening & evaluation – JPT

Application for TNA services will be selected under a peer-reviewed process. Only European user groups (from EU Member States or Associated States) can apply for the free services, and only to EURIPRED Service infrastructures outside their own country. For scientists based in countries outside the EU Member States or its Associated States, access is subject to a range of charges according to the service requested (see also Eligibility Criteria).

With agreement with EC, scientific excellence should be the main selection criterion i.e. objectives, feasibility, innovation, quality and record of investigators, quality of the proposed methodology, potential impact (need for knowledge dissemination, sustainability), compliance with national and international standards of research are considered to be sub-components of scientific excellence. Read more about the call procedure on our website

EURIRPED will continue to send out new calls every three months. In 2015 at the following dates new calls will be announced:

  • April 22 (Deadline: May 12): Reference material, Formulation, Microarray
  • July 01 (Deadline July 31): Reference material, Microarray
  • October 01 (Deadline: October 31): Reference material, Formulation, Microarray.
Read more about these calls

Euripred partner JPT Peptide Technologies organises a practical course for immunologists on high throughput seroprofiling and antibody epitope mapping using peptide microarrays.
Learn how to get robust and reliable scientific results, easily and quickly.The course includes hands-on laboratory sessions, using JPT’s RepliTope™ and PepStar™ peptide microrrays and an introduction to evaluation and presentation of complex data using R. You will also get tutorials, tips and tricks and presentations by experienced peptide microarray specialists from JPT.

Venue: JPT Peptide Technologies GmbH, Volmerstrasse 5, 12489 Berlin, Germany
Date: April 21 – 23, 2015
The participation of the course, travel and accomodation are free of charge through the Euripred project.  Read more about the agenda and how to register

EURIPRED partner Eatris, together with Helmholtz Centre for Infection Research (HZI) in Braunschweig, Germany, organises two on-site lab courses (five-day hands-on training) for up to 6 participants at the labs of the research group vaccinology at the HZI:

  • Lab course I:  Mucosal vaccination strategies and immunomonitoring (5-9 October 2015)
  • Lab course II:  Multifunctional T cells and intracellular cytokines (2016)
Target group for both courses: Scientists performing animal studies for developing vaccine related technologies or preclinical validation of vaccine candidates. More information. To apply for lab course I, please complete this application form and send it before 15 May to Dr Thomas Ebensen

This training course, consisting of a 2 week practical course for up to 2 participants in October, will take place at the HIV Biology and Variability Unit, National Centre for Microbiology, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain.
Contents of the training:

  • HIV primary isolation from patients’ PBMCs, by coculture with PBMCs from healthy donor, previously stimulated, in accordance with the AIDS Clinical Trial Group (ACTG) VRL protocol.
  • Coreceptor (CCR5 and/or CXCR4) usage determination of HIV primary isolates by infecting GHOST-CCR5 and GHOST-CXCR4 cells.
  • Near full-length genome sequencing of HIV primary isolates
  • Phylogenetic sequence analysis by maximum likelihood and analysis of recombination by bootscanning.
Target group:
  • Scientists interested in the availability of well characterized HIV isolates for vaccine candidate assessment, for neutralization studies to assess the humoral immune responses and for studies on HIV molecular diagnostic techniques.
  • Scientists interested in the use of methods for phylogenetic HIV sequence analysis and characterization of HIV genetic forms.
The training will be held on 19-23 and 26-30 October 2015. ISCIII's HIV Biology and Variability Unit will pay for the costs for preparing and carrying out the training course. The participants will be responsible for travel and accommodation costs. If you want to join this training course, please complete this application form before 15 May and send it to Dr. Lucía Pérez Álvarez and Dr. Miguel Thomson. For more information you can contact Lucía Pérez Álvarez.

Euripred partner University of Lausanne organises, together with WHO, the fourth course on adjuvants and vaccine formulation. This course is part of the ADITEC project, also funded by the European Commission.

Dates: 15-19 June 2015
Location: Vaccine Formulation Laboratory at University of Lausanne, Switzerland

Various adjuvant systems, such as Aluminum salts / Water-in-Oil emulsions / Oil-in-Water emulsions / TLR agonists / Liposomes / Virosomes / QS21 / ISOMs

This 5-day course will focus on the different vaccine adjuvant systems and will give an overview on best practices in formulation of adjuvanted vaccines. In addition, background information on the immune system and process development, characterization, quality control, preclinical development, clinical development and regulatory aspects of adjuvanted vaccines will be provided. Read more about the eligibility criteria and how to apply

Copyright © 2012 TBVI
To unsubscribe , please click here